Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TScan Therapeutics, Inc. | 1,165,000 | reported | 20 Jan 2026 | tx 9+3,531,300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jan 2026 | GRANT_AWARD | TScan Therapeutics, Inc. | 1,165,000 | 0.00 USD | deriv |
| 03 Jan 2025 | GRANT_AWARD | TScan Therapeutics, Inc. | 800,000 | 0.00 USD | deriv |
| 12 Jan 2024 | GRANT_AWARD | TScan Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | TScan Therapeutics, Inc. | 1,121,300 | 0.00 USD | deriv |
| 02 Feb 2023 | GRANT_AWARD | TScan Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 25 Jul 2022 | GRANT_AWARD | TScan Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | TScan Therapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 21 Sept 2021 | PURCHASE | TScan Therapeutics, Inc. | 57 | 6.19 USD | |
| 20 Sept 2021 | PURCHASE | TScan Therapeutics, Inc. | 4,943 | 6.22 USD |